Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
[An efficacy comparison of betahistin, trimetazidine and ginkgo biloba extract in patients with tinnitus]
The severity of the consequences depends on the specific medication and its therapeutic window
From 300 consultation + 8,000/month programme entry (medications additional, depending on prescription)
Despite favorable cost-effectiveness, ICER projected affordability concerns: at current net prices of $6,830 for semaglutide and $7,973 for tirzepatide, fewer than 1% of eligible adults in the United States could be treated before surpassing ICERs budget impact threshold of $880 million annually
US$ 20.09
US$ 20.88
US$ 28.66
US$ 20.85
US$ 29.67
US$ 25.44
US$ 22.25
